Peachtree Investment Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-352
Closed -$204K 134
2025
Q4
$204K Buy
+352
New +$199K 0.07% 93
2024
Q4
Sell
-455
Closed -$282K 122
2024
Q3
$282K Buy
+455
New +$269K 0.11% 70
2022
Q3
Sell
-437
Closed -$238K 95
2022
Q2
$238K Sell
437
-435
-50% -$239K 0.15% 70
2022
Q1
$515K Sell
872
-121
-12% -$69.5K 0.24% 62
2021
Q4
$663K Buy
+993
New +$620K 0.28% 48

Other funds holding TMO

Peachtree Investment Partners's TMO Position: Q1 2026 in Review

Peachtree Investment Partners sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 352 shares — an estimated $204K sold.

Peachtree Investment Partners first reported a position in TMO in Q4 2021 and held it in 5 quarters. The position peaked at $663K in Q4 2021. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Peachtree Investment Partners reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
  • Peachtree Investment Partners sold 352 Thermo Fisher Scientific shares in Q1 2026, an estimated $204K.
  • Peachtree Investment Partners first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 5 quarters.
  • Peachtree Investment Partners's Thermo Fisher Scientific position peaked at $663K in Q4 2021.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Peachtree Investment Partners's 13F filing for Q1 2026, filed 8 May 2026.